Bioalpha in vaccine distribution MoU


BurIn a filing with Bursa Malaysia, it said the contract was effective since Jan 22, and subject to approval from the relevant authorities for the distribution and sale of the vaccine.

KUALA LUMPUR: Bioalpha Holdings Bhd’s subsidiary has entered a memorandum of understanding (MoU) with Zuellig Pharma Sdn Bhd for the import and distribution of the Covid-19 vaccine in Malaysia.

In a filing with Bursa Malaysia, it said the contract was effective since Jan 22, and subject to approval from the relevant authorities for the distribution and sale of the vaccine.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Bioalpha , vaccine , distribution , Zuellig Pharma ,

   

Next In Business News

AIA new business value soars 27%, adds US$2bil to buybacks
Fed rate-cut debate shifts from ‘when’ to ‘if’ on inflation data
Reconsidering Eurasia connectivity and trade
Billionaire Geiger nears L’Occitane buyout
Mega bid, copper prices expose industry concerns
Elliott builds large stake in Japan trading firm Sumitomo
BYD shares face earnings test as China’s EV price war heats up
New accounting software not needed for e-invoicing
Capital A's aviation segment records 90% load factor, 15.4 mln passenger volume in 1Q
QSR Brands confirms temporary closure of KFC outlets amid economic challenges

Others Also Read